Pulse Biosciences (PLSE)
(Real Time Quote from BATS)
$17.24 USD
-0.09 (-0.52%)
Updated Oct 14, 2025 01:30 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Pulse Biosciences, Inc has a market cap of $1.17B, which represents its share price of $17.33 multiplied by its outstanding shares number of 67.30M. As a small-cap company, PLSE's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PLSE 17.24 -0.09(-0.52%)
Will PLSE be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for PLSE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PLSE
Pulse Biosciences Unveils Promising First-in-Human Data for nPulse
Pulse Biosciences Gets FDA IDE Nod for Atrial Fibrillation Study
PLSE: What are Zacks experts saying now?
Zacks Private Portfolio Services
PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment
Other News for PLSE
Is PLSE signaling a buying opportunity? 200 Day Moving Average Support shows up after dropping 1.53%
Fell Below 20 Day Moving Average appears for PLSE after 8.57% move
Pulse Biosciences Reveals Promising Study Results
PLSE's price falls by 3.46% on October 9, though its technical setup remains stable.
PLSE forms Pocket Pivot on October 8